The current study looked at the effect of 8 weeks supplementation (4–5 mg/day) with ribose-cysteine in the apoE-/- mouse model of atherosclerosis over a time period (20 weeks of age) at which disease develops [21]. The gene discussed is APOE; the disease is atherosclerosis.